abstract |
Compositions and methods for treating cancer and bone density abnormalities comprising agents that prevent or counteract antagonism of Wnt signaling mediated by DKK1 and / or DKK4. Antibodies and fragments that bind to the protein target Dickkopf (DKK1), and methods of use and kits for treating target cells, particularly cells associated with osteolytic conditions. [Selection figure] None |